Dyslipidemia

>

Latest News

Digitial illustration of lipid disorders in the blood stream. | Credit: Fotolia
Zerlasiran Further Cements Lp(a)-Lowering Potential in Phase 2 ALPACAR-360 Trial

March 18th 2024

Silence Therapeutics' announcement of topline data from the ALPACAR-360 trial shows promising results for zerlasiran in reducing Lp(a) levels.

Doctor writing a prescription for a patient. | Credit: Fotolia
Despite Progress, Access to PCSK9 Inhibitors Remains Subpar Among US Patients

March 13th 2024

US FDA logo in black over a white background. | Credit: US Food and Drug Administration
Alirocumab Approved for Heterozygous Familial Hypercholesterolemia in Patients 8 Years and Older

March 11th 2024

Jessica Reese, PhD | Credit: University of Oklahoma
Study Raises Red Flag on Rates of Elevated, Abnormal Cholesterol Among American Indian Youth

March 8th 2024

Ron Blankstein, MD | Credit: Brigham and Women's Hospital
Elevated Lp(a) Levels Linked to Cardiovascular Event Risk, Regardless of ASCVD History

March 4th 2024

Video Series
Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.